Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 292

Similar articles for PubMed (Select 23645782)

1.

Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.

Pesta M, Fichtl J, Kulda V, Topolcan O, Treska V.

Anticancer Res. 2013 May;33(5):2239-43.

PMID:
23645782
2.

Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.

Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J.

Cancer Res. 2001 Mar 15;61(6):2523-32.

3.

Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer.

Zieglschmid V, Hollmann C, Mannel J, Albert W, Jaeschke-Melli S, Eckstein B, Hillemann T, Greten TF, Gross E, Böcher O.

Anticancer Res. 2007 Jul-Aug;27(4A):1823-32.

4.

Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.

Uen YH, Lin SR, Wu DC, Su YC, Wu JY, Cheng TL, Chi CW, Wang JY.

Ann Surg. 2007 Dec;246(6):1040-6.

PMID:
18043108
5.

Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases.

Hinz S, Bockhorst J, Röder C, Egberts JH, Schafmayer C, Küchler T, Becker T, Kalthoff H.

Ann Surg Oncol. 2012 Aug;19(8):2539-46. doi: 10.1245/s10434-012-2291-9. Epub 2012 Mar 7.

PMID:
22395998
6.

Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells.

Lankiewicz S, Rother E, Zimmermann S, Hollmann C, Korangy F, Greten TF.

Cell Oncol. 2008;30(6):463-71.

PMID:
18936523
7.

Unique localization of circulating tumor cells in patients with hepatic metastases.

Jiao LR, Apostolopoulos C, Jacob J, Szydlo R, Johnson N, Tsim N, Habib NA, Coombes RC, Stebbing J.

J Clin Oncol. 2009 Dec 20;27(36):6160-5. doi: 10.1200/JCO.2009.24.5837. Epub 2009 Nov 2.

8.

Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients.

Shimada R, Iinuma H, Akahane T, Horiuchi A, Watanabe T.

Oncol Rep. 2012 Apr;27(4):947-53. doi: 10.3892/or.2012.1649. Epub 2012 Jan 19.

9.

Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis.

Pilati P, Mocellin S, Bertazza L, Galdi F, Briarava M, Mammano E, Tessari E, Zavagno G, Nitti D.

Ann Surg Oncol. 2012 Feb;19(2):402-8. doi: 10.1245/s10434-011-2132-2. Epub 2011 Nov 10.

PMID:
22071867
10.

Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.

Mikulová V, Cabiňaková M, Janatková I, Mestek O, Zima T, Tesařová P.

Scand J Clin Lab Invest. 2014 Mar;74(2):132-42. doi: 10.3109/00365513.2013.864784. Epub 2013 Dec 19.

PMID:
24350991
11.

Clinical impact of carcinoembryonic antigen messenger ribonucleic acid expression in tumor-draining vein blood on postoperative liver metastasis in patients with colorectal carcinoma: a prospective, cohort study.

Sunouchi K, Machinami R, Mori M, Namiki K, Hattori S, Murata Y, Tsuchiya T, Mizuno H, Tadokoro M.

Dis Colon Rectum. 2003 Apr;46(4):467-73.

PMID:
12682539
13.

Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer.

Iinuma H, Okinaga K, Egami H, Mimori K, Hayashi N, Nishida K, Adachi M, Mori M, Sasako M.

Int J Oncol. 2006 Feb;28(2):297-306.

PMID:
16391782
14.

Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.

Iinuma H, Watanabe T, Mimori K, Adachi M, Hayashi N, Tamura J, Matsuda K, Fukushima R, Okinaga K, Sasako M, Mori M.

J Clin Oncol. 2011 Apr 20;29(12):1547-55. doi: 10.1200/JCO.2010.30.5151. Epub 2011 Mar 21.

15.

Detection of hematogenic tumor cell dissemination in patients undergoing resection of liver metastases of colorectal cancer.

Weitz J, Koch M, Kienle P, Schrödel A, Willeke F, Benner A, Lehnert T, Herfarth C, von Knebel Doeberitz M.

Ann Surg. 2000 Jul;232(1):66-72.

16.

Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer.

Guller U, Zajac P, Schnider A, Bösch B, Vorburger S, Zuber M, Spagnoli GC, Oertli D, Maurer R, Metzger U, Harder F, Heberer M, Marti WR.

Ann Surg. 2002 Dec;236(6):768-75; discussion 775-6.

18.

Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.

Zhao S, Yang H, Zhang M, Zhang D, Liu Y, Liu Y, Song Y, Zhang X, Li H, Ma W, Zhang Q.

Cell Biochem Biophys. 2013 Mar;65(2):263-73. doi: 10.1007/s12013-012-9426-2.

PMID:
22990361
19.
20.

Detection of circulating tumor cells in peripheral blood of colorectal cancer patients without distant organ metastases.

Liu Y, Qian J, Feng JG, Ju HX, Zhu YP, Feng HY, Li DC.

Cell Oncol (Dordr). 2013 Feb;36(1):43-53. doi: 10.1007/s13402-012-0112-6. Epub 2012 Nov 14.

PMID:
23150200
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk